Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Humana ( (HUM) ) has issued an update.
Humana Inc. announced its preliminary 2026 Medicare Advantage Star Ratings, revealing that approximately 20% of its members are enrolled in plans rated 4 stars and above, with an average Star rating of 3.61. The company is executing a contract diversification strategy to improve future ratings and expects a higher percentage of members in top-rated plans by 2027. Despite not being satisfied with the 2026 ratings, Humana is confident in its operational improvements and strategic initiatives, anticipating a return to Top Quartile results for the 2027 Star Ratings. Additionally, Humana affirmed its 2025 earnings guidance, projecting approximately $13.77 in GAAP EPS and $17.00 in adjusted EPS, reflecting confidence in its core business operations and strategic planning.
The most recent analyst rating on (HUM) stock is a Hold with a $290.00 price target. To see the full list of analyst forecasts on Humana stock, see the HUM Stock Forecast page.
Spark’s Take on HUM Stock
According to Spark, TipRanks’ AI Analyst, HUM is a Outperform.
Humana’s overall stock score is driven by strong earnings call results and solid financial performance. The raised EPS guidance and strategic growth initiatives are significant positives. However, technical indicators suggest weak momentum, and valuation metrics indicate a moderate valuation, balancing the overall score.
To see Spark’s full report on HUM stock, click here.
More about Humana
Humana Inc. operates in the healthcare industry, primarily offering Medicare Advantage plans and related services. The company focuses on providing health insurance products and services to individuals and groups, with a significant emphasis on Medicare plans.
Average Trading Volume: 1,799,425
Technical Sentiment Signal: Strong Sell
Current Market Cap: $29.68B
Learn more about HUM stock on TipRanks’ Stock Analysis page.